07:00 , Oct 13, 2014 |  BC Week In Review  |  Financial News

TVM Capital financial update

The seventh fund had targeted $200 million. Last year, TVM said it would cease investing in IT companies, a year after the fund's initial close at $150 million. The firm has $1.3 billion under management....
02:24 , Oct 7, 2014 |  BC Extra  |  Financial News

TVM closes Fund VII at $201.6M

TVM Capital Life Science announced the final closing of its TVM Life Science Ventures VII at $201.6 million. Lead investors included Teralys Capital and Eli Lilly and Co. (NYSE:LLY). Also participating were Business Development Bank...
07:00 , Sep 30, 2013 |  BioCentury  |  Finance

Broader minded in Canada

Broader minded in Canada With C$135 million ($131 million) for its second healthcare fund, the venture arm of the Business Development Bank of Canada is hoping to achieve top quartile returns so that when BDC...
07:00 , Sep 23, 2013 |  BC Week In Review  |  Financial News

BDC Venture Capital financial update

The Business Development Bank of Canada (BDC) has allocated C$135 million ($131 million) to its BDC Venture Capital venture arm for a new healthcare fund. The BDC Venture Capital Healthcare Fund will invest in Canadian...
01:29 , Sep 19, 2013 |  BC Extra  |  Financial News

BDC Venture Capital receives C$135M for new healthcare fund

The Business Development Bank of Canada (BDC) has allocated C$135 million ($131 million) to its BDC Venture Capital venture arm for a new healthcare fund. The BDC Venture Capital Healthcare Fund will invest in Canadian...
07:00 , Apr 2, 2012 |  BC Week In Review  |  Financial News

Merck financial update

Merck invested $40 million across two life science funds managed by Lumira Capital, including $35 million to help launch the Merck Lumira Biosciences Fund. The fund, which raised $43 million in its first close, will...
00:43 , Mar 27, 2012 |  BC Extra  |  Financial News

Merck invests $40M in Lumira funds

Merck & Co. Inc. (NYSE:MRK) invested $40 million across two life science funds managed by Lumira Capital, including $35 million to help launch the Merck Lumira Biosciences Fund. The fund, which raised $43 million in...
07:00 , Jun 20, 2011 |  BC Week In Review  |  Financial News

Milestone Pharmaceuticals completes venture financing

Milestone Pharmaceuticals Inc. , Montreal, Quebec   Business: Cardiovascular   Date completed: 6/13/11   Type: Venture financing   Raised: C$13 million (US$13.3 million)   Investors: Pappas Ventures; Business Development Bank of Canada; GO Capital Fund;...
07:00 , Jun 20, 2011 |  BioCentury  |  Finance

Making the Milestone

Making the Milestone The venture arm of the Business Development Bank of Canada helped lead a C$13 million ($13.3 million) series A round last week in cardiovascular play Milestone Pharmaceuticals Inc. The financing is intended...
23:56 , Jun 13, 2011 |  BC Extra  |  Financial News

Milestone raises $13.3 million

Milestone Pharmaceuticals Inc. (Montreal, Quebec) raised C$13 million ($13.3 million) in an equity round led by new investors Pappas Ventures; the Business Development Bank of Canada; and GO Capital. Fonds de solidarite FTQ, also a...